We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth (UNH) Buys Crystal Run to Boost Value-Based Care
Read MoreHide Full Article
UnitedHealth Group Incorporated (UNH - Free Report) has purchased the New York-based physician group Crystal Run Healthcare, per reports. Although there has been no public disclosure about the acquisition from either party, one of the first sources to bring the buyout into the public eye was Mid Hudson News.
Per the source, the acquisition was closed in February 2023 and management of the acquiree confirmed joining the health services business of UnitedHealth Group which is Optum.
Shares of UnitedHealth Group gained 1.2% in the last couple of days.
The acquisition aims to leverage the collective expertise of both healthcare providers and extend high-quality value-based care across the Hudson Valley and lower Catskill region. Crystal Run’s credible network comprising 400 doctors will enable the UNH unit to gain an in-depth understanding of the diversified needs of local communities.
The initiative marks the growing inclination of managed care companies like UnitedHealth Group to work closely with primary care providers and bring more patients under the ambit of a value-based care model. Value-based care fetches multiple benefits for patients, some of which include increased preventive screenings that result in the early diagnosis and treatment of a disease, higher patient engagement and declining emergency room visits. It also assures to bring down the healthcare expenses of patients.
By extending high-quality care, delving into underserved areas and offering a hassle-free experience for patients, physicians, nurses and other providers across the targeted communities, the footprint of Optum is likely to receive a boost.
Such efforts reinforce UnitedHealth Group’s consistent efforts to better serve its existing members and attract new ones through its subsidiary. The Optum unit of UNH leverages clinical prowess, technology and data to extend an innovative product offering suite to people, partners and providers.
Last year, the business benefited on the back of an increase in value-based care arrangements and an expansive care delivery services suite.
Shares of UnitedHealth Group have gained 1.6% in the past six months compared with the industry’s 1.3% growth. UNH currently carries a Zacks Rank #3 (Hold).
ICON’s earnings surpassed estimates in each of the last four quarters, the average surprise being 2.26%. The Zacks Consensus Estimate for ICLR’s 2023 earnings indicates a 7.7% improvement from the prior year’s estimate, while the same for revenues suggests 4.9% growth. The consensus mark for ICLR’s 2023 earnings has moved north by 1% in the past 60 days.
The bottom line of Humana outpaced estimates in each of the trailing four quarters, the average surprise being 12.95%. The Zacks Consensus Estimate for HUM’s 2023 earnings indicates a 11.2% improvement from the prior year’s reported figure, while the same for revenues suggests 11.1% growth. The consensus mark for HUM’s 2023 earnings has moved north by 0.2% in the past 60 days.
IDEXX Laboratories’ earnings surpassed estimates in each of the last four quarters, the average surprise being 3.59%. The Zacks Consensus Estimate for IDXX's 2023 earnings indicates a 19.2% improvement from the prior year’s reported figure, while the same for revenues suggests 7.9% growth. The consensus mark for IDXX’s 2023 earnings has moved north by 0.3% in the past 30 days.
Shares of ICON, Humana and IDEXX Laboratories have rallied 19.9%, 6.4% and 45.1%, respectively, in the past six months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth (UNH) Buys Crystal Run to Boost Value-Based Care
UnitedHealth Group Incorporated (UNH - Free Report) has purchased the New York-based physician group Crystal Run Healthcare, per reports. Although there has been no public disclosure about the acquisition from either party, one of the first sources to bring the buyout into the public eye was Mid Hudson News.
Per the source, the acquisition was closed in February 2023 and management of the acquiree confirmed joining the health services business of UnitedHealth Group which is Optum.
Shares of UnitedHealth Group gained 1.2% in the last couple of days.
The acquisition aims to leverage the collective expertise of both healthcare providers and extend high-quality value-based care across the Hudson Valley and lower Catskill region. Crystal Run’s credible network comprising 400 doctors will enable the UNH unit to gain an in-depth understanding of the diversified needs of local communities.
The initiative marks the growing inclination of managed care companies like UnitedHealth Group to work closely with primary care providers and bring more patients under the ambit of a value-based care model. Value-based care fetches multiple benefits for patients, some of which include increased preventive screenings that result in the early diagnosis and treatment of a disease, higher patient engagement and declining emergency room visits. It also assures to bring down the healthcare expenses of patients.
By extending high-quality care, delving into underserved areas and offering a hassle-free experience for patients, physicians, nurses and other providers across the targeted communities, the footprint of Optum is likely to receive a boost.
Such efforts reinforce UnitedHealth Group’s consistent efforts to better serve its existing members and attract new ones through its subsidiary. The Optum unit of UNH leverages clinical prowess, technology and data to extend an innovative product offering suite to people, partners and providers.
Last year, the business benefited on the back of an increase in value-based care arrangements and an expansive care delivery services suite.
Shares of UnitedHealth Group have gained 1.6% in the past six months compared with the industry’s 1.3% growth. UNH currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the Medical space are ICON plc (ICLR - Free Report) , Humana Inc. (HUM - Free Report) and IDEXX Laboratories, Inc. (IDXX - Free Report) . While ICON currently sports a Zacks Rank #1 (Strong Buy), Humana and IDEXX Laboratories carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ICON’s earnings surpassed estimates in each of the last four quarters, the average surprise being 2.26%. The Zacks Consensus Estimate for ICLR’s 2023 earnings indicates a 7.7% improvement from the prior year’s estimate, while the same for revenues suggests 4.9% growth. The consensus mark for ICLR’s 2023 earnings has moved north by 1% in the past 60 days.
The bottom line of Humana outpaced estimates in each of the trailing four quarters, the average surprise being 12.95%. The Zacks Consensus Estimate for HUM’s 2023 earnings indicates a 11.2% improvement from the prior year’s reported figure, while the same for revenues suggests 11.1% growth. The consensus mark for HUM’s 2023 earnings has moved north by 0.2% in the past 60 days.
IDEXX Laboratories’ earnings surpassed estimates in each of the last four quarters, the average surprise being 3.59%. The Zacks Consensus Estimate for IDXX's 2023 earnings indicates a 19.2% improvement from the prior year’s reported figure, while the same for revenues suggests 7.9% growth. The consensus mark for IDXX’s 2023 earnings has moved north by 0.3% in the past 30 days.
Shares of ICON, Humana and IDEXX Laboratories have rallied 19.9%, 6.4% and 45.1%, respectively, in the past six months.